This week on Exponential: Alzheimer’s is a disease that is claiming more and more people, and so far little progress has been made either on a cure or even on a way to slow it progress meaningfully. But, a small American company thinks it may have the key. It plans to start clinical trials of its drugs a few months from now, and if it’s successful, it will be a blockbuster. I talked to the CEO of Alzheon, Martin Tolar.